Movement Alert|Axon Enterprise, Inc. Rises 5.03% in Regular Trading, Morgan Stanley Affirms Clean Q2 Results Amid Oversold Rebound

Market Focus08-08

On August 7, Axon Enterprise, Inc. rose 5.03% in regular trading, trading at $548.85/share, with turnover of $254 million. The rebound followed Morgan Stanley's research note affirming the quality of the company's Q2 earnings after the stock had been dragged lower by a broad AI software sector selloff.

Morgan Stanley stated that Axon delivered \"clean\" Q2 results, with $15.1 billion in future contracted bookings meeting expectations, signaling a healthy underlying demand environment. The firm now expects Axon to deliver revenue growth of 33% in 2026 and 34% in 2027, citing continued traction across its broader product portfolio including counter-drone and international markets. Q2 revenue came in at $904.4 million, up 35.3% year-over-year, exceeding the consensus estimate of $876.4 million. The company also raised its full-year revenue growth guidance to 32%-34%, up from 30%-32% previously.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment